BOSAYA
Live / Applied — Second extension granted (statement of use) (as of 24 Oct 2025)
What this means for you
Not registered yet, but its 06 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98535396
- Mark type
- Stylized text
- Filed
- 06 May 2024
- Published for opposition
- 19 Nov 2024
- Attorney of record
- Bentley J. Olive
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, medical and biological preparations for treatment of osteoporosis in postmenopausal women; pharmaceutical, medical and biological preparations for increasing bone mass in men with osteoporosis; pharmaceutical, medical and biological preparations for treatment of glucocorticoid-induced osteoporosis; pharmaceutical, medical and biological preparations for treatment of bone loss in men receiving androgen deprivation therapy for prostate cancer; pharmaceutical, medical and biological preparations for treatment of bone loss in women receiving adjuvant aromatase inhibitor therapy for breast cancer
Owner
- Biocon Biologics Limited, Bengaluru, Karnataka, IN
- Biocon Biologics Limited, Bengaluru, Karnataka, IN
Prosecution history
- 24 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Oct 2025 — SOU EXTENSION 2 GRANTED
- 30 May 2025 — SOU EXTENSION 2 FILED
- 24 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 May 2025 — SOU TEAS EXTENSION RECEIVED
- 30 May 2025 — SOU EXTENSION 1 GRANTED
- 30 May 2025 — SOU EXTENSION 1 FILED
- 30 May 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Nov 2024 — PUBLISHED FOR OPPOSITION
- 13 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED